11 results
Lymphomas and Lymphoproliferative Disorders - Differential Diagnosis Algorithm
Hodgkin Lymphoma ~40% - Characteristic For Reed-Sternberg (RS) Cells
B-Cell ~90% • Low ... Responsive to Treatment ... , Most common, Wide ... growth, response to treatment ... Classification #pathophysiology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Perforation) Pathophysiology ... Tx Management (IDSA ... Fidaxomicin is now ... /severe CDI IDSA ... 2021 CDI Treatment
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... susceptible (or has low ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Digoxin Pharmacology and Pathophysiology
1) Na/K ATPase Pump - Digoxin works by directly binding to and inhibiting
Digoxin Pharmacology ... and Pathophysiology ... potassium levels) is a side ... hypokalemia (or low ... #Pathophysiology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
condition with a wide ... mental status and low ... & Dry) is the treatment ... & Dry” is the treatment ... icu #clinical #pharmacology
The crusade against “Ab”Normal Saline continues.  This is a non-physiologic fluid that can harm our
this post will focus ... , the ICF must now ... reduces renal blood flow ... management #diagnosis #treatment ... #pharmacology #
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
effects in the treatment ... Fluconazole - Benefits: Low ... monitoring advised, low ... Coccidioidomycosis #pharmacology ... #management #treatment
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
IDSA Recommendations ... : • The best treatment ... patients with low ... Microsporidiosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... dysfunction is low ... #Cryptococcus #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... KS: • Since low ... recommended for KS treatment ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology